Alexander Morss is a Cardiology physician. OpenAlex indexes 7 publications with 269 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9427 SW Barnes Rd Ste 495
Portland, OR 972256612
Telephone
503-216-1661Provider last certified this registry record 15 Feb 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20252 payments
- Boston Scientific CorporationProgram year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.4%Beta blocker19.6%Metoprolol Succinate60%Carvedilol26%Metoprolol Tartrate12%Atenolol3%Part D≥143 patientsStatin15.8%Atorvastatin Calcium62%Rosuvastatin Calcium28%Pravastatin Sodium7%Simvastatin2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
12.4%Factor Xa inhibitor9.6%Eliquis87%Xarelto14%Part D≥103 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D≥16 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.7%Potassium supplement4.2%Potassium Chloride92%Klor-Con M208%Part D<11 patientsSGLT2 inhibitor1.5%Jardiance71%Farxiga29%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Differences in left ventricular ejection fraction using teichholz formula and volumetric methods by cmr: implications for patient stratification and selection of therapy
Journal of Cardiovascular Magnetic Resonance
2010 - Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock*
Critical Care Medicine
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”